Search
Type 2 Diabetes Clinical Trials in Durham, NC
A listing of 2 Type 2 Diabetes clinical trials in Durham, NC actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 2 of 2
The city of Durham, North Carolina, currently has 2 active clinical trials seeking participants for Type 2 Diabetes research studies.
Featured Trial
Type 2 Diabetes (T2DM) Clinical Study
Recruiting
A clinical study for people that suffer with Type 2 Diabetes (T2DM)
Conditions:
Type 2 Diabetes (T2DM)
Featured Trial
Chronic Kidney Disease (CKD) Clinical Study
Recruiting
A clinical study for people that suffer with Chronic Kidney Disease (CKD)
Conditions:
Chronic Kidney Disease (CKD)
Featured Trial
Cardiovascular Disease Clinical Study
Recruiting
A clinical study for people that suffer with Cardiovascular Disease
Conditions:
Cardiovascular Disease
Featured Trial
ASCVD A Clinical Study
Recruiting
A clinical study for people that suffer with ASCVD
Conditions:
ASCVD A
ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Atherosclerotic Cardiovascular Disease
Atherosclerotic Cardiovascular Diseases
Featured Trial
ASCVD B Clinical Study
Recruiting
A clinical study for people that suffer with ASCVD
Conditions:
ASCVD B
ASCVD
Atherosclerotic Cardiovascular Disease
Atherosclerotic Cardiovascular Disease (ASCVD)
Atherosclerotic Cardiovascular Diseases
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US
Recruiting
This study has 3 aims. Aim 1: Identify social determinants of cardiometabolic health and determine facilitators and modifiable barriers in achieving treatment goals.
Aim 2: Assess PLWH knowledge, skills, and confidence for self-management of cardiometabolic disorders.
Aim 3: Tailor a self-management support and education intervention with stakeholder input to address barriers to achieving treatment goals for cardiometabolic disorders in PLWH at the study sites.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/23/2025
Locations: Duke University - Duke Study Site, Durham, North Carolina
Conditions: Hypertension, Dyslipidemias, Type 2 Diabetes, HIV-1-infection
CardioRenal Effects of SGLT2 Inhibition in Kidney Transplant Recipients
Recruiting
CREST-KT is a single-center, double-blinded, randomized trial of empagliflozin therapy in 72 kidney transplant recipients with (n=36) and without type 2 diabetes (n=36). After evenly dividing patients by type 2 diabetes diagnosis, patients will be randomized 2:1 to empagliflozin 10mg versus placebo.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/05/2025
Locations: Duke University Medical Center, Durham, North Carolina
Conditions: Kidney Transplant; Complications, Diabetes Mellitus, Type 2
1 - 2 of 2
